Skip to content

In the BioHarmony Drug Report Database

Vestronidase alfa

Mepsevii (vestronidase alfa) is an enzyme pharmaceutical. Vestronidase alfa was first approved as Mepsevii on 2017-11-15. It has been approved in Europe to treat mucopolysaccharidosis VII.
Trade Name Mepsevii
Common Name Vestronidase alfa
Indication mucopolysaccharidosis vii
Drug Class Enzymes; estrogens
Vestronidase alfa
Get full access now